Vascular Solutions
First single-use, remotely operated endovascular robotic system for peripheral navigation
Company profile
Company profile
Microbot Medical is a medical device company pioneering a new category of single-use robotic systems for interventional procedures. The company's flagship product, LIBERTY® Endovascular Robotic System, is the first disposable, remotely operated robotic platform designed for peripheral vascular navigation. The system enables interventional physicians to perform endovascular procedures from a seated position with remote control guidance, delivering precise catheter and guidewire manipulation while significantly reducing radiation exposure. LIBERTY® was designed to lower traditional barriers to robotic adoption by eliminating the need for large capital equipment, extensive infrastructure changes, or additional staffing resources. The compact, single-use design integrates seamlessly into existing workflows while maintaining the precision and responsiveness physicians require. Clinical evidence from the ACCESS-PVI trial demonstrated 100% successful robotic navigation across all cases with zero adverse device effects and a 92% relative reduction in operator radiation exposure. The company serves interventional radiologists, vascular surgeons, and interventional cardiologists performing peripheral vascular procedures. Microbot Medical's mission is to deliver transformative interventional robotic solutions that prioritize patient care, empower providers, and enable access to advanced care anytime, anywhere. Led by co-founder and CEO Harel Gadot, the company is transitioning from clinical studies to commercialization, positioning itself to redefine the future of minimally invasive interventional procedures through accessible robotic technology.
Company description Microbot Medical official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
On Premise deployment with recorded integration context.
Company milestones
Completed ACCESS-PVI clinical trial with successful outcomes, transitioning from clinical studies to commercialization phase, building commercial sales team
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
First single-use, remotely operated endovascular robotic system for peripheral navigation
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of vascular and interventional radiology : JVIR · May 1, 2026
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
All cases in ACCESS-PVI trial
ACCESS-PVI trial safety profile
Operator radiation exposure during procedures
Remote-controlled endovascular navigation with miniature robotic system
100% successful robotic navigation, 0 adverse device effects, 92% relative reduction in radiation exposure
Interventional oncology procedures using LIBERTY system
Easy setup and effortless target navigation for interventional oncology
Robotic interventional procedures replacing bulky capital equipment
Completed over 100 robotic cases; LIBERTY breaks down barriers compared to larger equipment
Clinical adoption of LIBERTY Robotic System for interventional radiology
Physician endorsement addressing clinical and financial needs
Adoption of robotic endovascular system for interventional procedures
Physician endorsement for future of robotics in interventional field
05 · Leadership
Leadership profiles and professional links from the current Company record.
Harel Gadot
CEO, President and Chairman
Simon Sharon
GM, Chief Technology Officer
Rachel Vaknin
Chief Financial Officer
Juan Diaz-Cartelle
Chief Medical Officer
Earl Adamy
VP, Strategic Marketing & Business Development
Christina Bailey
VP, Sales
Eran Cohen
VP, Global Integration
Naama Moav
VP, Human Resources
06 · Company updates
Recent articles published on Microbot Medical's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.